Annual Operating Profit
-$361.36 M
-$10.75 M-3.07%
December 31, 2023
Summary
- As of February 12, 2025, IBRX annual operating income is -$361.36 million, with the most recent change of -$10.75 million (-3.07%) on December 31, 2023.
- During the last 3 years, IBRX annual operating profit has fallen by -$151.14 million (-71.90%).
- IBRX annual operating profit is now -131.27% below its all-time high of -$156.25 million, reached on December 31, 2019.
Performance
IBRX Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Profit
-$80.25 M
+$19.08 M+19.21%
September 30, 2024
Summary
- As of February 12, 2025, IBRX quarterly operating income is -$80.25 million, with the most recent change of +$19.08 million (+19.21%) on September 30, 2024.
- Over the past year, IBRX quarterly operating profit has increased by +$19.08 million (+19.21%).
- IBRX quarterly operating profit is now -118.66% below its all-time high of -$36.70 million, reached on March 31, 2020.
Performance
IBRX Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Operating Profit
-$359.29 M
-$117.00 K-0.03%
September 30, 2024
Summary
- As of February 12, 2025, IBRX TTM operating income is -$359.29 million, with the most recent change of -$117.00 thousand (-0.03%) on September 30, 2024.
- Over the past year, IBRX TTM operating profit has dropped by -$117.00 thousand (-0.03%).
- IBRX TTM operating profit is now -878.92% below its all-time high of -$36.70 million, reached on March 31, 2020.
Performance
IBRX TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Profit Formula
Operating Profit = Gross Profit − Operating Expenses
IBRX Operating Profit Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -3.1% | +19.2% | -0.0% |
3 y3 years | -71.9% | +5.8% | +3.4% |
5 y5 years | -131.3% | +5.8% | +3.4% |
IBRX Operating Profit Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -9.4% | at low | -1.2% | +28.1% | -8.8% | +3.4% |
5 y | 5-year | -131.3% | at low | -118.7% | +28.1% | -878.9% | +3.4% |
alltime | all time | -131.3% | at low | -118.7% | +28.1% | -878.9% | +3.4% |
ImmunityBio Operating Profit History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | - | -$80.25 M(-19.2%) | -$359.29 M(+0.0%) |
Jun 2024 | - | -$99.33 M(+4.3%) | -$359.17 M(+4.1%) |
Mar 2024 | - | -$95.20 M(+12.7%) | -$344.98 M(-4.5%) |
Dec 2023 | -$361.36 M(+3.1%) | -$84.50 M(+5.4%) | -$361.36 M(+0.1%) |
Sep 2023 | - | -$80.14 M(-5.9%) | -$361.08 M(-2.9%) |
Jun 2023 | - | -$85.14 M(-23.7%) | -$371.75 M(+1.5%) |
Mar 2023 | - | -$111.58 M(+32.5%) | -$366.23 M(+4.5%) |
Dec 2022 | -$350.62 M | -$84.22 M(-7.3%) | -$350.62 M(+1.4%) |
Sep 2022 | - | -$90.80 M(+14.0%) | -$345.67 M(+3.6%) |
Jun 2022 | - | -$79.62 M(-17.0%) | -$333.70 M(-1.8%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2022 | - | -$95.97 M(+21.1%) | -$339.99 M(+2.9%) |
Dec 2021 | -$330.28 M(+57.1%) | -$79.27 M(+0.6%) | -$330.28 M(+3.7%) |
Sep 2021 | - | -$78.84 M(-8.2%) | -$318.39 M(+8.0%) |
Jun 2021 | - | -$85.91 M(-0.4%) | -$294.77 M(+13.5%) |
Mar 2021 | - | -$86.26 M(+28.0%) | -$259.78 M(+23.6%) |
Dec 2020 | -$210.22 M(+34.5%) | -$67.39 M(+22.0%) | -$210.22 M(+47.2%) |
Sep 2020 | - | -$55.22 M(+8.4%) | -$142.84 M(+63.0%) |
Jun 2020 | - | -$50.92 M(+38.7%) | -$87.62 M(+138.7%) |
Mar 2020 | - | -$36.70 M | -$36.70 M |
Dec 2019 | -$156.25 M | - | - |
FAQ
- What is ImmunityBio annual operating income?
- What is the all time high annual operating profit for ImmunityBio?
- What is ImmunityBio annual operating profit year-on-year change?
- What is ImmunityBio quarterly operating income?
- What is the all time high quarterly operating profit for ImmunityBio?
- What is ImmunityBio quarterly operating profit year-on-year change?
- What is ImmunityBio TTM operating income?
- What is the all time high TTM operating profit for ImmunityBio?
- What is ImmunityBio TTM operating profit year-on-year change?
What is ImmunityBio annual operating income?
The current annual operating profit of IBRX is -$361.36 M
What is the all time high annual operating profit for ImmunityBio?
ImmunityBio all-time high annual operating income is -$156.25 M
What is ImmunityBio annual operating profit year-on-year change?
Over the past year, IBRX annual operating income has changed by -$10.75 M (-3.07%)
What is ImmunityBio quarterly operating income?
The current quarterly operating profit of IBRX is -$80.25 M
What is the all time high quarterly operating profit for ImmunityBio?
ImmunityBio all-time high quarterly operating income is -$36.70 M
What is ImmunityBio quarterly operating profit year-on-year change?
Over the past year, IBRX quarterly operating income has changed by +$19.08 M (+19.21%)
What is ImmunityBio TTM operating income?
The current TTM operating profit of IBRX is -$359.29 M
What is the all time high TTM operating profit for ImmunityBio?
ImmunityBio all-time high TTM operating income is -$36.70 M
What is ImmunityBio TTM operating profit year-on-year change?
Over the past year, IBRX TTM operating income has changed by -$117.00 K (-0.03%)